Alnylam Pharmaceuticals (ALNY) PT Raised to $385 at Canaccord Genuity
Tweet Send to a Friend
(Updated - February 18, 2025 6:50 AM EST)
Canaccord Genuity analyst Whitney Ijem raised the price target on Alnylam ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Canaccord Genuity analyst Whitney Ijem raised the price target on Alnylam ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
